Willow bark extract (A pharmaceutically used extract BNO 1455) and its fractions (flavonoids, proanthocyanidins, salicyl alcohol derivatives) showed dose dependent cytotoxic effects against human colon and lung cancer irrespective of their COX-2 selectivity (Hostanska et al., 2007). This evidence concerns the gene PTGS2 and lung carcinoma.